Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Cardiology|October 3, 2019
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysisDaisuke Ueshima, Luca Nai Fovino, Sorin J Brener, et al.
American Heart Journal|March 1, 2014
Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trialsGiuseppe Tarantini, Sorin Jakob Brener, Alberto Barioli, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 8, 2018
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studiesGiuseppe Tarantini, Giulia Masiero, Alberto Barioli, et al.
Giornale Italiano Di Cardiologia (2006)|June 24, 2024
[Drug-eluting stents in contemporary interventional practice: the STENT PANORAMA project (Part I)]Giulia Masiero, Alberto Barioli, Marco Borghesi, et al.
International Journal of Cardiology|October 30, 2012
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experiencePaolo Buja, Gianpiero D'Amico, Michela Facchin, et al.
Journal of Cardiovascular Translational Research|December 20, 2015
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot StudyMichele Pighi, Fabrizio Tomai, Alessandro Petrolini, et al.
International Journal of Cardiology|January 25, 2016
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudyGiuseppe Tarantini, Luca Nai Fovino, Paola Tellaroli, et al.
Pageof 2